Hyperbaric enhancement of Coxsackievirus infection in mice
Orsi, E.V.; Mancini, R.; Barriso, J.
Aerospace Medicine 41(10): 1169-1172
1970
ISSN/ISBN: 0001-9402 PMID: 5458200 Document Number: 24101
Document emailed within 1 workday
Related Documents
Chen, Y. 1991: Enhancement of host defence against infection with Listeria monocytogenes in newborn mice by various recombinant cytokines Hokkaido Journal of Medical Science 66(1): 41-48Lin, J.Z. 1988: Pathological study of coxsackievirus B3m pancreatitis in mice Zhonghua Yi Xue Za Zhi 68(2): 88-90; 6-7
Barson, W.J.; Reiner, C.B. 1986: Coxsackievirus B2 infection in a neonate with incontinentia pigmenti Pediatrics 77(6): 897-900
Bocharov, E.F.; Shestenko, O.P. 1984: Immunological mechanisms in the pathogenesis of coxsackievirus infection Voprosy Virusologii 29(5): 516-521
Gaudin, O.G.; Bringuier, J.P.; Brigaud, M.; Terraillon, J.; Sohier, R. 1971: Immunologic response of 3 animal species (guinea-pigs, hamsters, mice) to different coxsackievirus A. I. Comparative study of complement fixing antibodies Annales de l'Institut Pasteur 120(2): 228-242
Song, J.; Hu, Y.; Li, J.; Wang, J.; Guo, L.; Zheng, H.; Ning, R.; Wang, L.; Li, Q.; Liu, L. 2016: Expression of Type-Ι Interferon Production Pathway-Related Genes Induced by Infection Due to Enterovirus 71 or Coxsackievirus A16 in Normal Human Airway Epithelial Cells Bing du Xue Bao 32(6): 694-701
Wernersson, S.; Karlsson, M.C.; Dahlström, J.; Mattsson, R.; Verbeek, J.S.; Heyman, B. 1999: IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice Journal of Immunology 163(2): 618-622
Roikhel, V.M.; Fokina, G.I.; Sobolev, S.G.; Korolyev, M.B.; Pogodina, V.V. 1984: Effect of hyperbaric oxygenation on experimental scrapie in mice Acta Virologica 28(4): 294-299
Reap, E.A.; Felix, N.J.; Wolthusen, P.A.; Kotzin, B.L.; Cohen, P.L.; Eisenberg, R.A. 1995: Bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy Journal of Immunology 155(11): 5455-5462
Frolova, M.A.; Gudkova, R.G.; Bol'shukhina, L.A.; Novoselova, V.N. 1978: Enhancement phenomenon in mice with a heterotopic heart transplant Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 36-40
Oliver, J.H.; Little, J.M.; Pirch, J.H. 1970: Effect of reserpine and other drugs on the CNS and lethal effects of hyperbaric oxygen in mice Archives Internationales de Pharmacodynamie et de Therapie 183(2): 215-223
Korosteleva, T.A.; Aleksanian, I.T.; Movsesian, K.S. 1973: Enhancement of the immunity against a transplanted cell culture of hepatoma 22a in mice Voprosy Onkologii 19(8): 72-76
Mohr, S.J.; Chirigos, M.A.; Fuhrman, F.; Smith, G. 1976: Enhancement of a tumor allograft in BALB/c x DBA/2 F1 mice by pyran copolymer Cancer Research 36(4): 1315-1319
Viaggi, C.; Vaglini, F.; Pardini, C.; Sgadò, P.; Caramelli, A.; Corsini, G.U. 2007: CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity Journal of Neural Transmission. Supplementum 2007(72): 159-163
Warr, G.W.; Sljivić, V.S. 1974: Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum Clinical and Experimental Immunology 17(3): 519-532
Medina, D. 1977: Enhancement of mammary tumor formation in mice by a cytostatic drug, melphalan Cancer Research 37(1): 317-319
Peraino, C.; Fry, R.J.; Staffeldt, E. 1973: Brief communication: Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital Journal of the National Cancer Institute 51(4): 1349-1350
Joanny, P.; Mialon, P.; Cann-Moisan, C.; Caroff, C.; Steinberg, J. 2000: Regional brain bioamine levels under hyperbaric oxygen in two unequally susceptible strains of mice Aviation Space and Environmental Medicine 71(9): 929-934
Yin, J.; Li, G.-Q.; Yu, Y.; Shi, Y.; Sun, B.-C.; Cheng, F.; Ge, W.-G.; Wang, X.-H. 2008: Mechanism of enhancement of the CTL activity in mice co-expressing CD80, CD86 and CD137L genes Zhonghua Zhong Liu Za Zhi 30(9): 654-658
Darnowski, J.W.; Handschumacher, R.E. 1985: Tissue-specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine Cancer Research 45(11 Part 1): 5364-5368